Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Horizon Therapeutics (DE:HPR)
FRANKFURT:HPR
Horizon Therapeutics (HPR) Ownership - Who Owns Horizon Therapeutics?
0 Followers
Horizon Therapeutics (HPR) Ownership Overview
0.00% Insiders
0.00% Mutual Funds
1.33% Other Institutional Investors
98.67% Public Companies and
Individual Investors
The ownership structure of Horizon Therapeutics (DE:HPR) stock is a mix of institutional, retail and individual investors. Approximately 1.33% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 98.67% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 02, 2023 | Thomas Watkins Director | Bought | $1106550 |
| Oct 02, 2023 | Gino Santini Director | Bought | $351691 |
| Oct 02, 2023 | James Samuel Shannon Director | Bought | $144452 |
| Sep 28, 2023 | Michael Grey Director | Bought | $319200 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2023 | Bought | $271524 | |
| Jun 30, 2023 | Bought | $2057000 | |
| Jun 30, 2023 | Bought | $2221560 | |
| Jun 30, 2023 | Bought | $3502042 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 75,681 | Insider | ― | 8,340,046 | |
| 12,766 | Insider | ― | 1,406,813 | |
| 20,477,359 | Institution | ― | 2,256,604,962 | |
| 22 | Institution | ― | 2,424 | |
| 21,562 | Institution | ― | 2,376,138 | |
| 55,161 | Institution | ― | 6,078,748 | |
| 17,154 | Institution | ― | 1,890,371 | |
| 75,118 | Institution | ― | 8,278,004 | |
| 3,289 | Institution | ― | 362,448 | |
| 1,821 | Institution | ― | 200,674 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 133,973 | Institution | ― | 14,763,825 | |
| 2,437,894 | Institution | ― | 268,655,919 | |
| 90,210 | Institution | ― | 9,941,142 | |
| 53,148 | Institution | ― | 5,856,910 | |
| 66,567 | Institution | ― | 7,335,683 | |
| 193,688 | Institution | ― | 21,344,418 | |
| 260,346 | Institution | ― | 28,690,129 | |
| 134,189 | Institution | ― | 14,787,628 | |
| 1,804,833 | Institution | ― | 198,892,597 | |
| 271,898 | Institution | ― | 29,963,160 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Horizon Therapeutics (DE:HPR)?
According to the latest TipRanks data, approximately 1.33% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 98.67% is held by retail investors.
What percentage of Horizon Therapeutics (DE:HPR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.33% of Horizon Therapeutics (DE:HPR) stock is held by institutional investors.
What percentage of Horizon Therapeutics (DE:HPR) stock is held by retail investors?
According to the latest TipRanks data, approximately 98.67% of Horizon Therapeutics (DE:HPR) stock is held by retail investors.
Who owns the most shares of Horizon Therapeutics (DE:HPR)?
MOZE BARRY owns the most shares of Horizon Therapeutics (DE:HPR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.